Air Pollution and Cardiometabolic Study

Cardiovascular Outcomes Clinical Trial

Official title:

Characterization and Health Risk Assessment of Exposure to Source-Specific PM2.5 in Subjects in Beijing

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02601352
• Other study ID #: WHuang15_17
• Status: Completed
• First received: November 3, 2015
• Last updated: April 3, 2018
• Start date: September 2015
• Est. completion date: January 2016

Study information

• Verified date: April 2018
• Source: Peking University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study mainly focuse on examining the subjects living in traffic polluted area and assessing the popuation health risk using disease and risk assessment models.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: January 2016
• Est. primary completion date: January 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Living in PU community neighborhood,Non smoker and No diseases ,and so on.

Exclusion Criteria:

• Advanced microvascular or neuropathic complications and active cardiovascular disease,and so on.

Related Conditions & MeSH terms

• Cardiovascular Outcomes

Locations

Country	Name	City	State
China	Peking University	Beijing	Beijing
China	Peking University ,School of Public Health	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
WeiHuang

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Vascular endothelial function	Vascular endothelial function measured by Endo-PAT2000	Four months
Primary	Arrythmias	Twenty four-hour electrocardiograms	Four months
Secondary	System inflammatory	Analyzed systemic inflammation biomarkers,such as C-reaction Protein and Blood coagulation by ELISA	Four months